Benzinga | Sep 23, 2021 09:10AM EDT

NeuroOne Medical Technologies Corporation Announces Successful Completion Of Feasibility Study For Ablation Electrode

NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) (NeuroOne or the Company), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it successfully completed an animal feasibility study of its combination recording and ablation technology at T3 Labs and Georgia State/Georgia Tech Center for Advanced Brain Imaging in Atlanta Georgia under the guidance of Dr. Robert Gross of Emory University. The study evaluated the ability of the NeuroOne Evo(r) sEEG electrodes to record brain activity and then ablate brain tissue using radiofrequency thermocoagulation in a porcine model.